GPGrace H. Panter

Grace H. Panter

*This is an algorithmically generated author record based on publicly available information.

Grace H. Panter has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The fathead minnow extended one generation reproduction test (FEOGRT): A design for regulatory application

    by Grace H Panter, Rebecca J Brown, Jeffrey C Wolf, Joseph P Marini, Samuel K Maynard, Valentin Mingo, James R Wheeler

    The fathead minnow (Pimephales promelas) is a well-established test species for aquatic (eco-)toxicology testing, including regulatory use in fish life-cycle toxicity tests and tests for endocrine disruption. Given its extensive use and available supporting historical data, the fathead minnow extended one generation reproduction test (FEOGRT) under discussion is similar in test design to the Japanese medaka (Oryzias latipes; MEOGRT) and zebrafish (Danio rerio; ZEOGRT) extended one generation tests. This test incorporates key life stages and endpoints across three generations, enabling detection of both manifest and potential transgenerational toxicity. It includes mechanistic information on endocrine sensitive parameters, such as vitellogenin, male secondary sex characteristics, sex ratio and gonadal histopathology, and parameters useful for assessing adversity (i.e., growth, development and reproduction). The FEOGRT design is 6 weeks longer in duration than the MEOGRT and requires more fish (<50%) compared to alternative ‘EOGRT’ test designs; however, it does offer several advantages. The fathead minnow is a common model used in lower tier testing (e.g., fish short-term reproduction assay or fish early life-stage test). For example, existing data sets can inform on the FEOGRT, which often negates the requirement for additional range-finding studies, it offers species concordance, and increases the options for testing laboratories. The fathead minnow is often preferred over fish species such as zebrafish and medaka due to its ease of culturing and handling, extensive validation in test guidelines, laboratory experience, clear external secondary sex differences, and the availability of historical control data. The proposed FEOGRT design does not require extensive validation since it follows adopted test guidelines in which the fathead minnow is already a recommended test species. The findings of the current review considers that the FEOGRT is a robust and regulatory-acceptable test, comparable to MEOGRT and ZEOGRT, offering a useful approach for assessing reproductive and endocrine toxicity in fish.


  • A Decision Logic for the Reliability Assessment and Interpretation of Vitellogenin Measurements

    by Rebecca J. Brown, Grace H. Panter, Natalie Burden, Lennart Weltje, James R. Wheeler, Edward R. Salinas, Yvonne Wolf, Laurent Lagadic


  • Open Access

    Detection of anti-androgenic activity of chemicals in fish studies: a data review

    by Grace H. Panter, Rebecca J. Brown, Alan Jones, Oliver Körner, Laurent Lagadic, Lennart Weltje

    A systematic review was conducted on the sensitivity of fish testing guidelines to detect the anti-androgenic activity of substances. Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS) was used to investigate the conservation of the androgen receptor (AR) between humans and fish, and among fish species recommended in test guidelines. The AR is conserved between fish species and humans (i.e. ligand binding domain [LBD] homology ≥70%) and among the recommended fish species (LBD homology >85%). For model anti-androgens, we evaluated literature data on in vitro anti-androgenic activity in fish-specific receptor-based assays and changes in endpoints indicative of endocrine modulation from in vivo studies. Anti-androgenic activity was most consistently and reliably detected in in vitro and in vivo mechanistic studies with co-exposure to an androgen (spiggin in vitro assay, Rapid Androgen Disruption Activity Reporter [RADAR] Assay, and Androgenised Female Stickleback Screen). Regardless of study design (Fish Short-Term Reproduction Assay [FSTRA], Fish Sexual Development Test [FSDT], partial or full life-cycle tests), or endpoint (vitellogenin, secondary sexual characteristics, gonadal histopathology, sex ratio), there was no consistent evidence for detecting anti-androgenic activity in studies without androgen co-exposure, even for the most potent substances (while less potent substances may induce no (clear) response). Therefore, based on studies without androgen co-exposure (35 FSTRAs and 22 other studies), the other studies (including the FSDT) do not outperform the FSTRA for detecting potent anti-androgenic activity, which if suspected, would be best addressed with a RADAR assay. Overall, fish do not appear particularly sensitive to mammalian anti-androgens.